Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Bupropion 150 mg
DRUG
2 trials
Sponsors
Janssen Research & Development, LLC
, Uppsala University
Conditions
Cardiometabolic Syndrome
Healthy
Obesity and Cardiovascular Risk
Overweight , Obesity
Phase 1
A Study to Evaluate the Effect of Oral Doses of JNJ-54175446 on the Inhibition of Cytochrome P450 CYP3A4, CYP2C9, CYP1A2 and CYP2D6 Activity and the Induction of CYP2B6 and CYP2C19 Activity Using a Multiple Probe Substrate Cocktail in Healthy Subjects
Completed
NCT03058419
Janssen Research & Development, LLC
Healthy
Start: 2017-03-14
End: 2017-05-15
Updated: 2017-06-08
Phase 3
Lifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Cardiometabolic Risk
Not yet recruiting
NCT07806279
Uppsala University
Cardiometabolic Syndrome, Obesity and Cardiovascular Risk, Overweight , Obesity
Start: 2026-10-30
End: 2030-12-31
Target: 250
Updated: 2026-09-08